Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia

Clinical trial NCT06613217 · RECRUITING

Trial details

NCT number: NCT06613217
Sponsor: Pacylex Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Adult AML

Start date: 2025-03-03
Primary completion: 2026-03-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.